We found that p16 is upregulated in tumor-infiltrating T cells, including those in mouse melanoma cancer (B16) and colorectal cancer (MC38) models (Fig. 1A and Supplementary Fig. S1A). This evidence concerns the gene CDKN2A and neoplasm.